110 related articles for article (PubMed ID: 34394823)
1. Methylation of CALCA and CALCB in Pancreatic Ductal Adenocarcinoma.
Gao F; Liu G; Wang J; Huang S; Ding F; Lian W; Lv X; Guo Y; Fan X; Zhang S; Liu Q
Oxid Med Cell Longev; 2021; 2021():2088345. PubMed ID: 34394823
[TBL] [Abstract][Full Text] [Related]
2. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.
Schinke T; Liese S; Priemel M; Haberland M; Schilling AF; Catala-Lehnen P; Blicharski D; Rueger JM; Gagel RF; Emeson RB; Amling M
J Bone Miner Res; 2004 Dec; 19(12):2049-56. PubMed ID: 15537449
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Pattern of CALCA and CALCB in Extremely Premature Infants with Monochorionic Triplets after Single-Embryo Transfer.
Gao F; Guo Y; Chen X; Gu Q; Huang S; Chen Q; Xu X; Zeng K; Zhou H; Zou Y; Liu Q
Oxid Med Cell Longev; 2021; 2021():1438837. PubMed ID: 34650662
[TBL] [Abstract][Full Text] [Related]
4. High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma.
Shen CC; Cui XY; He Y; Kang YH; Yi C; Yang JL; Gou LT
Pathol Oncol Res; 2015 Apr; 21(2):267-72. PubMed ID: 25079376
[TBL] [Abstract][Full Text] [Related]
5. Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism.
Li S; Li H; Ge W; Song K; Yuan C; Yin R
Technol Cancer Res Treat; 2020; 19():1533033820943237. PubMed ID: 32914707
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
7. CALCB rs3829222 T/T Genotype and Low Expression of CALCB Are High-Risk Factors for Adenoid Cystic Carcinoma of Salivary Gland.
Dai C; Zhang B; Liao Y; Liu Q; Wu F; Lv X; Zeng K; Zhu X
Dis Markers; 2021; 2021():5546858. PubMed ID: 34234876
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
[TBL] [Abstract][Full Text] [Related]
9. MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2.
Wang YD; Mao JD; Wang JF; Xu MQ
Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
Mohammed A; Qian L; Janakiram NB; Lightfoot S; Steele VE; Rao CV
Int J Cancer; 2012 Oct; 131(8):1951-62. PubMed ID: 22287227
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
[TBL] [Abstract][Full Text] [Related]
15. The role of CGRP and CALCA T-692C single-nucleotide polymorphism in psoriasis vulgaris.
Guo R; Li FF; Chen ML; Ya MZ; He HL; Li D
Pharmazie; 2015 Feb; 70(2):88-93. PubMed ID: 25997247
[TBL] [Abstract][Full Text] [Related]
16. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.
Duan J; Li X; Huang S; Zeng Y; He Y; Liu H; Lin D; Lu D; Zheng M
Mol Med Rep; 2018 Mar; 17(3):4187-4194. PubMed ID: 29344673
[TBL] [Abstract][Full Text] [Related]
17. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma.
Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y
Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503
[TBL] [Abstract][Full Text] [Related]
18. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
Zhang ML; Lu S; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice.
Schütz B; Mauer D; Salmon AM; Changeux JP; Zimmer A
J Comp Neurol; 2004 Aug; 476(1):32-43. PubMed ID: 15236465
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
